Acrivon Therapeutics
ACRV
#7853
Rank
$0.21 B
Marketcap
$6.96
Share price
-12.12%
Change (1 day)
34.10%
Change (1 year)

EPS for Acrivon Therapeutics (ACRV)

EPS in 2023 (TTM): -$2.50

According to Acrivon Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.50. In 2022 the company made an earnings per share (EPS) of -$2.30.

EPS history for Acrivon Therapeutics from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.508.7%
2022-$2.30